No Data
Sarepta Therapeutics to Present New Data From Its Neuromuscular Portfolio at 2024 World Muscle Society Congress
Sarepta Therapeutics (SRPT): Soaring With Successful Therapies and Cash Flow Positivity
Cantor Fitzgerald Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Maintains Target Price $152
Cantor Fitzgerald Sticks to Their Hold Rating for Sarepta Therapeutics (SRPT)
Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options
10 Health Care Stocks With Whale Alerts In Today's Session
Stock_Drift : I made a ton of bank the last time $Longeveron (LGVN.US)$ had run
but I got greedy and tried a second run and got hit like the Germans east flank during the battle of Stalingrad. Lol.
Clintzilla OP Stock_Drift : I like the algos for Long Long swing
Stock_Drift Clintzilla OP : Yeah, $Longeveron (LGVN.US)$ isn’t really a bag. They’ll run up again soon. Swing trade!! lol.